Huahai Pharmaceutical

Zhejiang Huahai Pharmaceutical Co., Ltd. was founded in 1989, and is a pharmaceutical enterprise integrating pharmaceutical preparations and APIs. It was listed on the Shanghai Stock Exchange in 2003. Currently, the company has a registered capital of 1.03 billion yuan, total assets of 20 billion yuan, covering an area of over 1.2 million square meters, and has over 30 branches (subsidiaries) in the United States, Shanghai, Jiangsu, Hangzhou, etc., with a total of over 8,500 employees.
The company is a national key high-tech enterprise, a national innovative enterprise, one of the top ten pharmaceutical enterprises in Zhejiang Province, and one of China's top 500 private enterprises. It was a pioneer enterprise in the internationalization of China's pharmaceutical industry during the 11th Five-Year Plan period. It has established a national-level enterprise technology center and a post-doctoral scientific research workstation, and is the first pharmaceutical enterprise in China to receive the title of "National Environmentally Friendly Enterprise."
Huahai Pharmaceutical is the first domestic pharmaceutical company to pass the U.S. FDA certification for its preparations and independently owns ANDA preparation approvals. It is currently one of the pharmaceutical enterprises in China with the most official certifications from international mainstream markets including the FDA, WHO, the EU, and Mexico. It is at the forefront of the domestic pharmaceutical industry in preparation export and international development, and is currently the only pharmaceutical enterprise in China capable of large-scale, commercial production and export of preparations to European and American markets.
The company is a leading enterprise in the domestic specialty API industry, particularly in the fields of cardiovascular ACE inhibitors and sartans. With core technology, it offers the widest variety of products internationally with leading technical levels, and is the world's largest supplier of ACE inhibitors and sartans.